Illuminate a path to consumer health success
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn MoreConnecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MOREEmpowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn moreWorking across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MOREDelivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreClinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn MoreHarness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MOREPharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MOREPrimary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORETrusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MOREOptimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MOREA single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MOREConnected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health needs innovative thinkers. Unleash your potential with us.
Search JobsDiscover how industry experts recognize IQVIA's impact across the Asia Pacific region.
LEARN MOREWhen the COVID-19 pandemic hit, we saw consumers look to online for their Consumer Health products like never before. At its peak in May 2020, 7% of all Consumer Health pharmacy sales were online. Now, ePharmacy accounts for 5% of all Consumer Health pharmacy sales (though remains up from 3% in 2019). The ability for Australian pharmacy retailers to pivot to online quickly limited the impact of the overall economic downturn.
Over the last 2 years, ePharmacy sales have grown at +70%, compared to the decline in brick and mortar pharmacy sales (-6%) and overall Consumer Heath pharmacy sales (-4%). Even compared to the peak lockdown period in May 2020 ePharmacy growth sits at +28%. Last year, I wrote about some of the headwinds facing online ePharmacy retailers during set up (read more here). Nearly one year on, let’s take a look at the latest ePharmacy trends:
We see ePharmacy continuing to grow at a rate of 30% yearly, with peaks in pandemic lockdown periods. The channel will continue to grow in importance, and 2023 ePharmacy predicted sales are expected to account for ~10% of all pharmacy sales, with some categories reaching over 20% of sales.
Certainly, consumer expectations of ePharmacy are growing, driven by developments in eCommerce in other industries. There is an opportunity for both retailers and manufacturers to seek a competitive advantage through the use of data and analytics. A comprehensive view of data will make it possible to capture insights, view the latest trends and shape strategy for success.
For more information, please feel free to contact us.
1 Australia Post, Inside Australian Online Shopping, eCommerce Industry Report, 2021.
Illuminate a path to consumer health success
Shape the future of consumer health.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.